Headline (SEO-Optimized, ≤60 characters):Actimed Secures Key Japan Patent for Muscle-Wasting Drug
London, UK – November 3, 2025 Actimed Therapeutics Ltd, a UK-based clinical-stage specialty pharmaceutical company, has announced the grant...
AI drug discovery Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
London, UK – November 3, 2025 Actimed Therapeutics Ltd, a UK-based clinical-stage specialty pharmaceutical company, has announced the grant...
